Stem cell therapy to treat symptoms of avian flu and other diseases

Abstract

The present disclosure relates to a method for the treatment of avian influenza using a stem cell preparation. Also described is a method for the manufacture of a stem cell preparation which can be used to treat the symptoms associated with avian influenza and a method for cryogenically preserving and/or storing a stem cell preparation which can be used to treat the symptoms associated with avian influenza. Also disclosed is a composition of matter containing stem cells which is useful for treating symptoms associated with avian influenza.

Description

Claims

1. A method for treating or preventing symptoms of avian influenza in a human subject comprising the steps of: a. providing a composition comprising a plurality of stems cells; andb. administering the composition to a human subject to treat of prevent symptoms associated with avian influenza.

2. The method of claim 1 wherein the composition comprises at least about 500,000 to over 5,000,000 stem cells.

3. The method of claim 2 wherein the composition comprises at least about 500,000 stem cells.

4. A pharmaceutical composition comprising: a. a dose of stems cells; andb. a pharmaceutically acceptable carrier,

5. The pharmaceutical composition of claim 4 wherein the dose of stem cells comprises at least about 500,000 to over 5,000,000 stem cells.

6. The pharmaceutical composition of claim 5 wherein the dose of stem cells comprises at least about 500,000 stem cells.

7. The method of claim 1 wherein the composition comprises at least about 200,000 stem cell;

8. The method of claim 4 wherein the composition comprises at least about 200,000 stem cell;

9. The method of claim 1 wherein the composition comprises between about 200,000 to about 10,000,000 stem cell;

10. The method of claim 4 wherein the composition comprises between about 200,000 to about 10,000,000 stem cell;

11. The method of claim 1 wherein the composition comprises about 50,000,000 stem cell;

12. The method of claim 4 wherein the composition comprises about 50,000,000 stem cell;

13. The method of claim 1 wherein the composition comprises a combination of different types of cells;

14. The method of claim 4 wherein the composition comprises a combination of different types of cells;

15. The method of claim 1 wherein the composition is administered as a single dose or multiple doses for at least two days;

16. The method of claim 4 wherein the composition is administered as a single dose or multiple doses for at least two days;

17. The method of claim 1 wherein the composition is administered daily for about two weeks;

18. The method of claim 4 wherein the composition is administered daily for about two weeks;